1227375-09-8 Usage
General Description
Bi-linderone is a novel synthetic compound that has been developed as a potential therapeutic agent for the treatment of cancer. It is a small molecule inhibitor that selectively targets and inhibits the activity of a key enzyme involved in cancer cell growth and proliferation. This enzyme is known to be overexpressed in many types of cancer and is therefore a promising target for the development of new anti-cancer drugs. Bi-linderone has shown promising results in preclinical studies, demonstrating potent anti-cancer activity in various cancer cell lines and animal models. It is currently being evaluated in clinical trials to determine its safety and efficacy in cancer patients, with the hope that it may become a valuable addition to the arsenal of anti-cancer drugs available for treating this devastating disease.
Check Digit Verification of cas no
The CAS Registry Mumber 1227375-09-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,2,7,3,7 and 5 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1227375-09:
(9*1)+(8*2)+(7*2)+(6*7)+(5*3)+(4*7)+(3*5)+(2*0)+(1*9)=148
148 % 10 = 8
So 1227375-09-8 is a valid CAS Registry Number.
1227375-09-8Relevant articles and documents
One-step biomimetic synthesis of (±)-linderaspirone A and (±)-bi-linderone
Wang, Gang-Qiang,Wei, Kun,Zhang, Lin,Feng, Tao,Wang, Fei,Wang, Qiu-An,Liu, Ji-Kai
, p. 2719 - 2721 (2011)
A one-step biomimetic synthesis of racemic linderspirone and bi-liderone from methyllinderone has been achieved, which probably reflects the biosynthesis of the natural products. There are few naturally occurring substances that appear to be formed by a [
